RecruitingNot ApplicableNCT06082466
FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial
Sponsor
Paracelsus Medical University
Enrollment
110 participants
Start Date
Sep 11, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this clinical trial is to analyze patency after autologous infrainguinal bypass surgery in patients receiving a venous conduit versus a covered venous conduit.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age at least 18 years
- Informed consent form with signature
- Rutherford Category 3 (<200m) or chronic critical ischemia (Rutherford Category 4-6)
- Assured inflow and recipient artery.
Exclusion Criteria10
- Pregnant or breastfeeding women
- Active infection or sepsis
- Acute ischemia
- Endovascular procedure in the region to be treated.
- Vein with outer diameter <3.5 mm or >8 mm under pressure.
- Spliced Veins.
- Known allergy to the cobalt-chromium alloy (ASTM 1058) or its components (Cobalt-Chromium-Iron-Nickel-Molybdenum).
- Vasculitis
- Coagulopathy
- Radiation therapy near the anastomosis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREFRAMED Infrainguinal Venous Bypass
The harvested vein graft will be covered with a mesh.
PROCEDUREConventional Autologous Bypass
The harvested vein graft will be used without a mesh coating.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06082466
Related Trials
Red Light Treatment in Peripheral Artery Disease
NCT032032391 location
Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia
NCT073528003 locations
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
NCT045846328 locations
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
NCT062773629 locations
VITUS Post-Market Registry
NCT0683263113 locations